CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted
Drug / intervention
Nitroglycerindrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00335010
NCT00335010N/ACompleted
CompareCT.gov

A Prospective Double Blinded Study on the Effect of Intravenously Administrated Nitroglycerine on Gastric Tissue Microvascular Bloodflow and Microvascular Hemoglobin Saturation During Gastric Tube Reconstruction

Erasmus Medical Center·interventional·Posted Jun 8, 2006·Updated Jun 8, 2006

In Brief

A clinical study evaluating Nitroglycerin for Esophageal Neoplasms and Microcirculation. Completed, across 1 site.

Detailed Summary

The aim of the present study was to investigate if NTG, administered intravenously during gastric tube reconstruction, could preserve gastric fundus tissue blood flow and oxygenation and reduce the incidence of postoperative leakage.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsEsophageal Neoplasms, Microcirculation
CountriesNetherlands
Collaborators--

Timeline

N/ACompletedFinished
20052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJun 8, 2006
Enrollment StartMay 1, 2005
Study CompletionDec 1, 2005
TodayJul 2, 2026
Posted 20.1 years ago

Interventions

Nitroglycerindrug